HARRISON THOMAS L — SEC insider filings
SEC reporting owner CIK 1247340. 20 insider filings on record with FilingPulse; latest filed 2026-10-02.
Transaction summary — filings shown
Covers all 20 filings on record, filed 2021-03-25 to 2026-10-02. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 1 leg across 1 filing — 5,000 shares, $95,000 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 21.
- Largest priced transaction: purchase of 5,000 shares @ $19.00 ($95,000) in Advanced Flower Capital Inc., filed 2021-03-25.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Advanced Flower Capital Inc. (AFCG) | Director | 6 | 1 leg · 5,000 sh · $95,000 | — | 6 |
| AGENUS INC (AGEN) | Director | 10 | — | — | 11 |
| Acurx Pharmaceuticals, Inc. (ACXP) | Director | 4 | — | — | 4 |
Insider filings — HARRISON THOMAS L
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-10-02 | 4 | AGENUS INC (AGEN) | Grant/award (A): 4,443 @ $6.89 | EDGAR |
| 2026-08-11 | 4 | AGENUS INC (AGEN) | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2026-07-07 | 4 | AGENUS INC (AGEN) | Grant/award (A): 8,547 @ $3.58 | EDGAR |
| 2026-04-28 | 4 | AGENUS INC (AGEN) | Grant/award (A): 122,500 (derivative) @ $0 | EDGAR |
| 2026-04-22 | 4 | Acurx Pharmaceuticals, Inc. (ACXP) | Grant/award (A): 2,150 (derivative) @ $0 | EDGAR |
| 2026-04-13 | 4 | AGENUS INC (AGEN) | Grant/award (A): 9,228 @ $3.32 | EDGAR |
| 2026-01-05 | 4 | AGENUS INC (AGEN) | Grant/award (A): 7,691 @ $3.98 | EDGAR |
| 2025-11-24 | 4 | Advanced Flower Capital Inc. (AFCG) | Grant/award (A): 5,474 @ $2.74 | EDGAR |
| 2025-10-03 | 4 | AGENUS INC (AGEN) | Grant/award (A): 5,780 @ $5.01 | EDGAR |
| 2025-07-15 | 4 | AGENUS INC (AGEN) | Grant/award (A): 7,401 @ $3.46 · Grant/award (A): 17,500 (derivative) @ $0 | EDGAR |
| 2025-04-03 | 4 | AGENUS INC (AGEN) | Grant/award (A): 8,898 @ $2.88 | EDGAR |
| 2025-02-27 | 4 | Advanced Flower Capital Inc. (AFCG) | Grant/award (A): 1,792 @ $8.37 | EDGAR |
| 2024-08-08 | 4 | AGENUS INC (AGEN) | Grant/award (A): 7,500 (derivative) @ $0 | EDGAR |
| 2024-06-18 | 4 | Acurx Pharmaceuticals, Inc. (ACXP) | Grant/award (A): 12,000 (derivative) @ $0 | EDGAR |
| 2024-01-25 | 4 | AFC Gamma, Inc. (AFCG) | Grant/award (A): 1,282 @ $11.70 | EDGAR |
| 2023-06-16 | 4 | Acurx Pharmaceuticals, Inc. (ACXP) | Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
| 2023-01-05 | 4 | AFC Gamma, Inc. (AFCG) | Grant/award (A): 963 @ $15.57 | EDGAR |
| 2022-01-13 | 4 | AFC Gamma, Inc. (AFCG) | Grant/award (A): 5,000 (derivative) @ $0 | EDGAR |
| 2021-07-06 | 4 | Acurx Pharmaceuticals, Inc. (ACXP) | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2021-03-25 | 4 | AFC Gamma, Inc. (AFCG) | Purchase (P): 5,000 @ $19 · Grant/award (A): 700 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2021-03-23 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1247340 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs